May 25, 2016 — Technavio’s latest report on the U.S....
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.
Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater...
News | Atrial Fibrillation | May 19, 2016
May 19, 2016 — Physician-researchers in the College of Medicine at the University of Cincinnati have developed a...
Sponsored Content
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
News | Cath Lab | May 19, 2016
May 19, 2016 — St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR...
News | Ablation Systems | May 11, 2016
May 11, 2016 — Patients with Wolff-Parkinson-White syndrome who receive...
Sponsored Content
An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.
Feature | Atrial Fibrillation | September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time...
News | Pacemakers | May 09, 2016
May 9, 2016 — Results from a first-of-its-kind study identify a significant increase in the incidence of...
News | Antiplatelet and Anticoagulation Therapies | May 09, 2016
May 9, 2016 — A new study shows the use of...
News | Antiplatelet and Anticoagulation Therapies | May 09, 2016
May 9, 2016 — A new study has found an increased risk of dementia in patients with...
Sponsored Content
An example of an automated summary cardiac monitor report from Medicalgorithmics' PocketECG system. Most of the the report parameters can be opened as separate pages with additional automated report summaries and graphical data charts.
Blog | Remote Monitoring | June 20, 2018
There is a movement toward real-time, remote cardiac monitoring with the latest generation of...
News | Atrial Fibrillation | May 09, 2016
May 9, 2016 — A new study presented at the Heart Rhythm Society’s 37th Annual Scientific Sessions, found that among...
News | Antiplatelet and Anticoagulation Therapies | May 06, 2016
May 6, 2016 — Atrial fibrillation...
Technology | Left Atrial Appendage (LAA) Occluders | April 29, 2016
April 29, 2016 — AtriCure Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the AtriClip...
Sponsored Content
New cardiac monitoring technologies allow for longer duration data collection. The Medtronic Reveal Linq implantable cardiac monitor allows for 24/7 monitoring for up to three years. This might not be necessary for most patients, and there are several newer Holter monitors that can record up to several days or several weeks of data in real-time.
Blog | ECG Wireless Remote Access | May 23, 2018
New patient monitoring technologies with wireless connectivity have enabled a revolution in cardiac event and...
News | Atrial Fibrillation | April 20, 2016
April 20, 2016 — In the first large randomized trial to directly compare two approaches to preventing...
Videos | Left Atrial Appendage (LAA) Occluders | April 15, 2016
David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal...
News | Antiplatelet and Anticoagulation Therapies | April 08, 2016
April 8, 2016 — New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban)...
